October 2020
The Lancet
Stroke systems of care in low-income and middle-income countries: challenges and opportunities
JD Pandian, Y Kalkond, IA Sebastian, C Felix, G Urimubenshi, J Bosch
Read MoreOctober 2020
Euro Heart J
Salt and CVD: insufficient evidence to recommend low sodium intake
M O'Donnell, A Mente, MH lderman, AJB Brady, R Diaz, R Gupta, P Lopez-Jaramillo, FC Luf, TF Luscher, G Mancia, JFE Mann, D McCarron, M McKee, S Yusuf, et al
Read MoreOctober 2020
Lancet
PURE: Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis
S Narula, S Yusuf, M Chong, C Ramasundarahettige, S Rangarajan, S Bangdiwala, M van Eikels, K Leineweber, A Wu, M Pigeyre, G Pare
Read MoreOctober 2020
J Cardiac Failure
Quality of life and its determinants in heart failure patients at a major tertiary academic center in Ontario, Canada
B Fukakusa, A Magi, A Grinvalds, T McCready, S Yusuf, EM Lonn
Read MoreOctober 2020
Diabetes Care - ADA
PURE: Contrasting associations between diabetes and cardiovascular mortality rates in low-, middle-, and high-income countries
RM Anjana, V Mohan, S Rangarajan, HC Gerstein, U Venkatesan, P Sheridan, GR Dagenais, SA Lear, K Teo, K Karsidag, KF Alhabib, K Yusoff, N Ismail, PK Mony, P Lopez-Jaramillo, J Chifamba, LM Palileo-Villanueva, R Iqbal, A Yusufali, IM Kruger, A Rosengren, A Bahonar, K Zatonska, K Yeatese, R Gupta, W Li, L Hu, MO Rahman, PVM Lakshmi, T Iype, A Avezum, R Diaz, F Lanas, S Yusuf
Read MoreSeptember 2020
JAMA Cardiology
COMPASS subanalysis: Rivaroxaban and aspirin in patients with symptomatic lower extremity peripheral artery disease
E Kapplovitch, JW Eikelboom, L Dyal, V Aboyans, MT Abola, P Verhamme, A Avezum, KAA Fox, SD Berkowitz, SI Bangdiwala, S Yusuf, SS Anand
Read MoreSeptember 2020
Stroke AHA
COMPASS MRI substudy: Rivaroxaban for prevention of covert brain infarcts and cognitive decline
M Sharma, RG Hart, EE Smith, J Bosch, JW Eikelboom, SJ Connolly, L Dyal, KW Reeh, A Casanova, R Diaz, P Lopez-Jaramillo, G Ertl, S Stork, GR Dagenais, EM Lonn, L Ryden, AM Tonkin, JD Varigos, DL Bhatt, Kelley Branch, JL Probstfield, J-H Kim, M O'Donnell, D Vinereanu, K AA Fox, Y Liang, L Liu, J Zhu, N Pogosova, AP Maggioni, A Avezum, LS Piegas, K Keltai, M Keltai, SD Berkowitz, S Yusuf
Read MoreSeptember 2020
Current Developments in Nutrition
Maternal diet and the serum metabolome in pregnancy: robust dietary biomarkers generalizable to multi-ethnic birth cohorts [includes START, FAMILY]
RJ de Souza, M Shanmuganathan, A Lamri, SA Atkinson, A Becker, D Desai, MK Gupta, PJ Mandhane, TJ Moraes, KM Morrison, P Subbarao, KK Teo, SE Turvey, NC Williams, P Britz-McKibbin, SS Anand
Read MoreSeptember 2020
Am Heart J
G-CHF: A multinational registry to study the characteristics and outcomes of heart failure patients
P Joseph, H Dokainish, T McCready, A Budaj, A Roy, Gertl, J Esteban Gomez-Mesa, D Leong, J Ezekowitz, C Hage, F Lanas, AP Maggioni, K Sliwa, J Zhu, J Rouleau, K Balasubramanian, S Yusuf
Read MoreSeptember 2020
ADA Diabetes Care
PURE: White rice and incident diabetes: a study of 132,373 participants in 21 countries
B Bhavadharini, V Mohan, M Dehghan, S Rangarajan, S Swaminathan, A Rosengren, A Wielgosz, A Aveezum, P Lopez-Jaramillo, F Lanas, AL Dans, K Yeates, P Poirier, J Chifamba, KF Alhabib, N Mohammadifard, K Zatonska, R Khatib, MV Keskinler, L Wei, C Wang, X Liu, R Iqbal, R Yusuf, E Wentzel-Viljoen, AH Yusufali, R Diaz, NK Keat, PVM Lakshmi, N Ismail, R Gupta, LM Palileo-Villanueva, P Sheridan, A Mente, S Yusuf
Read MoreSeptember 2020
JACC
COMPLETE: Nonculprit lesion severity and outcome of revascularization in patients with STEMI and multivessel coronary disease
T Sheth, N Pinilla-Echeverri, R Moreno, J Wang, DA Wood, RF Storey, R Mehran, KR Bainey, M Bossard, S Bangalore, JD Schwalm, JL Velianou, N Valettas, M Sibbald, J Rodes-Cabau, J Ducas, EA Cohen, A Bagai, S Rinfret, DE Newby, L Feldman, SB Laster, IM Lang, JD Mills, JA Cairns, SR Mehta
Read MoreSeptember 2020
BMJ Open
ISLAND: How and why a multifaceted intervention to improve adherence post-MI worked for some (and could work better for others): an outcome-driven qualitative process evaluation
L Desveaux, M Saragosa, K Russell, N McCleary, J Presseau, HO Witteman, JD Schwalm, NM Ivers
Read MoreAugust 2020
CV Drugs & Therapy
Strategies to reduce out-of-pocket medication costs for Canadians living with heart failure
WF McIntyre, P Belesiotis, GR McClure, C Demers, G Chahill, A Hayes, G Sohi, W Bordman, RP Whitlock, EP Belley-Cote
Read MoreAugust 2020
J Clinical Hypertension
PURE: Low levels of awareness, treatment, and control of hypertension in Andean communities of Ecuador
C Felix, ME Baldeon, F Zertuche, M Fornasini, MJ Paucar, L Ponce, S Rangarajan, S Yusuf, P Lopez-Jaramillo
Read MoreAugust 2020
CV Research
Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153,152 middle-aged individuals
PG Joseph, JS Healey, P Raina, SJ Connolly, Q Ibrahim, R Gupta, A Avezum, AL Dans, P Lopez-Jaramillo, K Yeates, K Teo, S Yusuf, et al.
Read More